Objective: To identify the rate of successful antiepileptic drug (AED) withdrawal after resective surgery and the predictors of postwithdrawal seizure recurrence in patients with extratemporal epilepsy.
Beyond seizure freedom, patients cite freedom from AED as one of their major objectives of surgical treatment for AED-resistant epilepsy. 1, 2 Continued AED use may be associated with a wide range of side effects and considerable financial burden, especially for the patients living in resource-poor countries. 3 In the absence of any uniform guidelines, practice of postoperative AED withdrawal varies from epilepsy center to center. 4, 5 Because of fear of seizure recurrence and failure to regain seizure control upon AED reintroduction, and loss of driving privileges, many physicians and patients prefer to persist with AED even after successful epilepsy surgery. 4, 5 Various studies have reported that AED can be withdrawn in 30%-80% of patients following successful temporal lobe resective epilepsy surgery. 4,6 -9 Extratemporal epilepsies are quite heterogeneous with respect to size and extent of the epileptogenic lesions, their proximity to eloquent cortex, types of pathologies, and extent of surgical resections. The seizure outcome following extratemporal resections is generally less favorable as compared to temporal lobe resections. 10 -12 The rate of successful AED withdrawal and the predictors of postwithdrawal seizure relapse may be different too. The objectives of this study were to assess the feasibility of AED withdrawal following extratemporal resective surgery and to identify the predictors of seizure recurrence on attempted withdrawal. METHODS Patient selection and evaluation. From the detailed database maintained at the R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Trivandrum, Kerala, India, we reviewed the records of consecutive patients who had undergone resections involving frontal, parietal, and occipital lobes from September 1997 to May 2008 for AED-resistant seizures and had completed a minimum of 2 years of postoperative follow-up. We included patients who underwent extratemporal resections with temporal lobe resections either for dual pathology or as a part of multilobar resection, but excluded those who underwent hemispherectomy/hemispherotomy. All the patients had a standard presurgical evaluation as described by us in detail previously. 6, 13, 14 We made decisions for surgery after a thorough discussion in the multidisciplinary patient management conference based upon the concordance between electroclinical and MRI data.
Surgery.
We performed lesionectomy or lobectomy in patients with well-defined MRI lesions and concordant electroclinical data. Bilobar/multilobar resections were carried out for patients who had pathologies which extended beyond 1 lobe. In those patients selected noninvasively, we tailored the extent of resection based on the preoperative MRI and intraoperative gross pathologic findings. We included areas with very frequent or rhythmic spikes (Ն1/second) on acute electrocorticography (ECoG) within the resection if this could be done without the risk of incurring neurologic deficits. In those with absent/equivocal MRI lesions and in those who underwent invasive monitoring, we decided the extent of resection based upon the region of ictal EEG onset, frequent interictal spikes, and eloquent cortex.
Postoperative follow-up. All patients were followed up at 3 months, at 1 year, and then at yearly intervals after surgery. We used a detailed seizure scoring system to define seizure outcome. 15 Based on the seizure score during terminal 12-month period, we classified the outcome into seizure-free (completely free from both seizures and auras) and not seizure-free (any type of seizure recurrence). All the patients underwent a standard 40minute scalp EEG at each follow-up up to third postoperative year. 16 All surgical specimens were subjected for histopathologic examination and results were reviewed. Due to financial constrains, we could perform postoperative MRI in only 33 patients.
Postoperative AED management. All the seizure-free patients were planned for gradual AED withdrawal during postoperative follow-up. The AEDs were also withdrawn in patients who had early postoperative recurrence if they subsequently became seizure-free for 2 or more years. In those patients who were on 2 or more AEDs, AED withdrawal was started at the end of the third postoperative month, whereas it was started at completion of 1 year after surgery in those on 1 AED. We classified AED based on the order of introduction into primary, first addon, and second add-on. Though decision to withdraw 1 AED over the other was variable, 1 of the primary drugs (typically carbamazepine, oxcarbazepine, or phenytoin) was always withdrawn in the end. The reduction in doses was always done at every 2 months except in patients taking 3 or more AEDs, who underwent a more rapid withdrawal of the third AED. Usual rate of withdrawal for different AEDs was as follows: carbamazepine: 100 mg; oxcarbazepine: 150 mg; phenytoin: 50 mg; phenobarbi-tone: 15 mg; clobazam: 2.5 mg; lamotrigine: 25 mg; topiramate: 25 mg; levetiracetam: 250 mg; clonazepam: 0.25 mg; and zonisamide: 50 mg. Patients who complained of mood fluctuations or insomnia during AED withdrawal, who had cortical dysplasia as underlying pathology, and who underwent multilobar resections were maintained on the last minimal dose for 6 -9 months before total discontinuation. In a small minority of patients who were otherwise seizure-free and were candidates for complete AED withdrawal, AEDs were continued due to associated psychiatric comorbidity or patients' reluctance to stop AED. Patients were asked to contact personally or telephonically in case of seizure recurrence. Date of starting the tapering of each drug, date of last change, and dates of the initial 2 seizure recurrences were noted for all the patients.
Standard protocol approvals, registrations, and patient consents. All patients or their guardians provided written informed consent to be treated and the data pertaining to the management to be stored in a database approved by the Institution's Internal Review Board for experimental research. They also consented for utilization of the data for this study.
Statistical analysis.
We used time-to-event (from surgery to complete AED discontinuation) Kaplan-Meier survival curves to study the probability of AED freedom following surgery. Additionally, patients with and without seizure recurrence on AED tapering were compared using Mann-Whitney U test, Pearson 2 test, and Fisher exact test. Subsequently, we performed multiple logistic regression analysis with forward stepwise (likelihood ratio) method, with probability for entry of the variables fixed as 0.05 and for removal 0.10. All analyses were performed using SPSS version 17.0 (SPSS Inc., Chicago, IL).
RESULTS Cohort characteristics.
For the cohort of 106 patients (73 male, 33 female), mean age at onset of epilepsy was 7.4 Ϯ 5.5 years (range, 7 months-27 years), mean duration of epilepsy was 12.5 Ϯ 8.0 years (range, 1-41 years), and mean age at surgery was 19.7 Ϯ 8.7 years (range, 3-45 years). All except 2 of our patients had MRI-detected lesions. The lesion was confined to a single lobe in 60 (56.6%) patients: frontal lobes in 34, parietal lobes in 10, and occipital lobes in 16 patients. Forty-four patients (42%) had involvement of 2 or more lobes. Pathologically, gliosis was the most common abnormality, present in 44 patients, followed by focal cortical dysplasia and low-grade neoplasm, each in 24 patients, while 9 patients had vascular malformations. Twentyfive patients (including 2 with normal MRI) required invasive monitoring. We have summarized the seizure and AED therapy outcomes in figure 1.
Seizure outcome. At a mean follow-up period of 4.6 Ϯ 2.2 years (range, 2-11 years), 63 (59.4%) patients were seizure-free and aura-free during the terminal 1 year. Out of them, 40 (37.7%) had no seizure or aura during the entire postoperative period. Of the remaining 43 (40.6%) patients who continued to have postoperative seizures, 23 (21.7%) experienced reduction in seizure frequency in comparison to their preoperative status.
Immediate postoperative AED status. In the immediate postoperative period, 62 (58.1%) patients were on 2 AEDs, 39 (37.2%) were taking more than 2 AEDs, and 5 (4.8%) patients were on monotherapy.
Postoperative AED management. AED withdrawal was attempted in 94 (88.7%) patients. The remaining 12 patients were never seizure-free for a sufficient period of time to permit AED withdrawal. Median time of starting AED tapering was 5 months (range, 3-124 months). At last follow-up, AED could be completely stopped in 26 (24.5%) patients with a minimum postwithdrawal follow-up of 1 year and doses could be reduced in another 42 (40.5%) patients. The mean time required for complete AED discontinuation was 38 Ϯ 15 months (range, 19 -78 months). For the whole cohort, the cumulative probability (with 95% CI) of achieving complete AEDfree status was 20% (16%-24%) at fourth year, 34% (28%-40%) at sixth year, 40% (33%-47%) at eighth year, and 52% (40%-64%) at 10th year after surgery. For the subcohort in whom AED withdrawal was attempted, the same was 30% (24%-36%) at fourth year, 47% (39%-55%) at sixth year, and 55% (47%-64%) at eighth year after surgery (figure 2). AED withdrawal and seizure recurrence. Following attempted AED withdrawal, seizures recurred in 44 (46.2%) patients. In 43 patients, recurrence occurred while reducing AED; in 13 patients while reducing the primary AED, in 25 patients while reducing the first add-on AED, and in 5 patients while reducing the second add-on AED. Following seizure recurrence, 14 (31.8%) patients continued to have seizures even after AED optimization. Among the remaining 30 (68.2%) patients, 10 became seizurefree and others had only very infrequent seizures after AED optimization (auras only in 5, infrequent nocturnal seizures in 8, and 1-3 seizures per year in 7). In patients who developed recurrence on attempted taper, 21 (49%) required fewer AEDs in comparison to their prewithdrawal status. Out of 50 patients with no recurrence on AED taper, AED could be completely discontinued in 26 patients. The remaining 24 patients were still undergoing AED taper or were being maintained on the last remaining doses of a single AED either because of their fear of seizure recurrence (10 of them had seizure recurrence in early postoperative period) or because of associated psychiatric comorbidity.
Predictors of seizure recurrence following AED withdrawal. On univariate analysis, we found the following factors to be predictive of seizure recurrence: older age at surgery, longer duration of epilepsy, abnormal postoperative EEG, presence of early postoperative seizures, and FCD and gliosis as pathologic substrates (table 1) . On comparing between different pathologies, patients with localized lesions like low-grade neoplasms and vascular malformations had significantly lower risk of seizure recurrence as compared to those with focal cortical dysplasias and gliosis. There was no difference in the timing of starting AED taper in patients who recurred and those who did not recur (p ϭ 0.27). Out of 33 patients in whom postoperative MRI was available, 9 had incomplete resection and 24 patients had complete resection. We did not include MRI-defined completeness of resection in the analysis, because fewer than one-third of our patients had undergone postoperative MRI.
In the final regression model, we found presence of IED on EEG during first postoperative year and long preoperative duration of epilepsy to be significant predictors of seizure recurrence (table 2) . Based on the fitted logistic regression model, while the pre- Table 1 Predictors of seizure recurrence on attempted AED withdrawal by univariate analysis dicted probability of seizure recurrence on attempted AED taper in a patient with preoperative epilepsy duration of 5 years was 52% when IEDs were present and 26% when IEDs were absent, the corresponding rates increased to 60% and 33% with epilepsy duration of 10 years, and 75% and 49% with epilepsy duration of 20 years ( figure 3 ).
DISCUSSION
No guideline regarding AED management following successful extratemporal epilepsy surgery currently exists. In a study that reported AED status following both extratemporal and temporal neocortical resections in 223 patients, AED could be stopped in 27% of patients, which is similar to the AED discontinuation rate of 24% in our study. 17 Other studies that included patients who had undergone different epilepsy surgery procedures have reported AED discontinuation rates from 30% to 80%. 18 -22 Factors like inclusion of heterogeneous patient groups and variable AED withdrawal practices and durations of follow-up make it difficult to compare results from different studies. Nearly onefourth of our patients were either in the process of withdrawal or were on the last minimal dose of AED. These patients could become AED-free on longer follow-up, which would increase the proportion of AED-free patients. Due to the financial burden of continued AED use, stigma associated with AED use, and good family support in case of seizure recurrence, patients in India usually opt for AED discontinuation. 3, 6, 23 Thus, nearly all our eligible patients underwent AED withdrawal that minimized bias introduced by factors other than seizure freedom.
A recurrence rate of 47% on attempted AED withdrawal we observed is similar to the previously reported rate of 54% in patients who have undergone neocortical resections. 17 However, with similar AED withdrawal practice, only 25% of our patients with mesial temporal lobe epilepsy had seizure recurrences while reducing AED and 53% were AED-free at terminal follow-up. 6 Did our practice of early initiation of AED withdrawal at 3 months contribute to high relapse rate? However, we initiate AED withdrawal at the end of the third postoperative month only in those receiving 2 or more AEDs, as there is very little evidence to indicate that seizure control following surgery would be better in those patients who receive polytherapy compared to monotherapy. 24 In patients who are on a single AED, we initiate AED withdrawal only after completion of the first postoperative year. Therefore, we do not consider that this practice contributed to high seizure recurrence. Because we initiated AED withdrawal at similar times in majority of our patients, we cannot draw any conclusions regarding the ideal time to initiate AED tapering following extratemporal surgery.
AED withdrawal studies on patients who have undergone temporal lobe epilepsy surgeries have Abbreviation: AED ϭ antiepileptic drug.
Figure 3 Estimated probability of seizure recurrence in relation to preoperative duration of epilepsy and interictal epileptiform discharges (IED) on EEG during the first postoperative year
shown that more than 90% of patients whose seizures recur on withdrawal subsequently become seizure-free on reintroduction of AED. 4,6 -9 However, nearly one-third of our patients did not become seizure-free on further AED optimization. In the absence of any randomized trials comparing the relapse rates with and without AED tapering, it cannot be conclusively proven that whether these patients were inherently prone to relapse or this was precipitated by AED tapering. One study which compared the outcome of pediatric epilepsy surgeries before and after 1997 reported improved outcomes in post-1997 patients, which was attributed to the less aggressive AED withdrawal policy in the post-1997 era. 25 At the end of the second postoperative year, 58% of patients who underwent surgery before 1997 were seizure-free and 31% were not taking any AED.
In post-1997 patients, 77% were seizure-free while only 15% were not taking AEDs. In the Mayo Clinic study, which mainly included patients with temporal lobectomies, the seizure recurrence rate after complete AED withdrawal was 14% at 2 years while it was only 3% in patients who did not taper AED. 18 Similar to our results, 37 of 68 (54%) patients who underwent neocortical resections and had a seizure relapse while AED tapering did not become seizurefree subsequently. 17 We found that longer duration of epilepsy, an abnormal postoperative EEG, occurrence of early postoperative seizures, and the presence of poorly circumscribed pathologies like gliosis and FCD were associated with higher risk of seizure recurrence. While for patients with a preoperative epilepsy duration of 5 years, the probability of seizure recurrence was nearly 50% for those with IED and 25% for those without IED on postoperative EEG, for those who were operated after having had epilepsy for 20 years, the corresponding rates increased to 75% and 50%. Longer duration of epilepsy has been reported to be associated with increased risk of seizure recurrence on attempted AED withdrawal following temporal lobectomy as well as following neocortical resections. 6, 17 This is also in agreement with previous reports which suggested that longer epilepsy duration is associated with less favorable seizure outcome following temporal lobectomies 26 and tumor resections. 27 In a recent systematic review, we found that presence of IED on postoperative EEG is associated with a 7-fold risk of unfavorable outcome following extratemporal surgeries. 28 We have also reported that abnormal postoperative EEG is associated with a higher risk of seizure recurrence on attempted AED withdrawal following successful surgery for temporal lobe epilepsy. 16 The present results further indicate the usefulness of postoperative EEG in planning the AED withdrawal in patients following extratemporal surgeries and we recommend greater caution in attempting AED withdrawal in those with IED on postoperative EEG. Seizure outcome following surgery for well-localized pathologies like low-grade neoplasms and cavernous malformations is better than other pathologies like FCD and gliosis which tend to be less circumscribed on MRI. 27, 29, 30 In the absence of well-defined boundaries, completeness of resection cannot be assured. Completeness of resection has been documented to be one of the most important factors that determine the seizure outcome following extratemporal surgery. 31, 32 However, the definitions of completeness of resection have been quite variable across different studies. While intraoperative ECoG and intraoperative surgical findings have their own limitations in deciding completeness of resection, postoperative MRI is not always feasible, especially in countries with limited resources. Thus, only one-third of our patients underwent postoperative MRI. Additionally, these patients belonged to a selected group as they underwent postoperative MRI either because of continuing seizures or because of their ability to afford this investigation. Because of these reasons, we could not assess the predictive value of incomplete lesion resection on seizure recurrence.
We acknowledge the following additional limitations of our study. Although the data were prospectively maintained, the study design was retrospective. Our cohort was heterogeneous with respect to lesion location and pathologic substrates, which precludes generalization of our results. However, this is an inherent problem in extratemporal epilepsy surgery outcome studies that defies solution. Since AED withdrawal was started fairly early after surgery, it is possible that many recurrences that occurred during withdrawal would have occurred independent of AED withdrawal. Only through a randomized controlled study can this issue be addressed. Because some of our patients were still undergoing AED reduction when last seen, the proportion of patients in whom AED could be withdrawn might increase over a longer follow-up period.
